Skip to main content

Point72 Asset Management, L.P.

Position in NVCR — NovoCure Ltd

CIK 1603466 STAMFORD, CT

Position in NVCR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$14,839,161
+$3,195,748 QoQ
Shares Held
1,361,391
+51.2% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
9 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Derivatives in NVCR

reported options exposure · as of Jun 30, 2023
CallValue
$0
CallShares
0
PutValue
$622,500
PutShares
15,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $700,270,107 across 37 Medical Devices names. NVCR ranks #9 (2.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVCR

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,839,161 1,361,391
2025-12-31 $11,643,413 900,496
2025-09-30 $1,506,472 116,600
2025-06-30 $8,366,000 470,000
2024-03-31 $509,538 32,600
2023-12-31 $5,500,212 368,400
2023-09-30 $186,435 11,544
2023-06-30 $1,030,569 24,833
2023-06-30 $622,500 15,000
2022-12-31 $11,369,250 155,000